nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—CYP2B6—Ifosfamide—germ cell cancer	0.111	0.207	CbGbCtD
Loperamide—CYP2C8—Ifosfamide—germ cell cancer	0.0844	0.156	CbGbCtD
Loperamide—CYP2B6—Cisplatin—germ cell cancer	0.0542	0.1	CbGbCtD
Loperamide—ABCB1—Dactinomycin—germ cell cancer	0.0484	0.0897	CbGbCtD
Loperamide—CYP2C8—Etoposide—germ cell cancer	0.0403	0.0748	CbGbCtD
Loperamide—CYP3A4—Ifosfamide—germ cell cancer	0.0342	0.0634	CbGbCtD
Loperamide—ABCB1—Vinblastine—germ cell cancer	0.0303	0.0562	CbGbCtD
Loperamide—CYP2D6—Vinblastine—germ cell cancer	0.0286	0.0529	CbGbCtD
Loperamide—ABCB1—Cisplatin—germ cell cancer	0.0278	0.0515	CbGbCtD
Loperamide—ABCB1—Etoposide—germ cell cancer	0.0273	0.0506	CbGbCtD
Loperamide—POMC—adrenal medulla—germ cell cancer	0.0242	0.0958	CbGeAlD
Loperamide—CYP3A4—Vinblastine—germ cell cancer	0.0182	0.0337	CbGbCtD
Loperamide—ABCB1—Methotrexate—germ cell cancer	0.018	0.0334	CbGbCtD
Loperamide—CYP3A4—Etoposide—germ cell cancer	0.0164	0.0303	CbGbCtD
Loperamide—POMC—vagus nerve—germ cell cancer	0.0156	0.0617	CbGeAlD
Loperamide—POMC—cranial nerve—germ cell cancer	0.0119	0.047	CbGeAlD
Loperamide—Megacolon toxic—Methotrexate—germ cell cancer	0.00976	0.0991	CcSEcCtD
Loperamide—POMC—telencephalic ventricle—germ cell cancer	0.00964	0.0382	CbGeAlD
Loperamide—POMC—urine—germ cell cancer	0.00881	0.0349	CbGeAlD
Loperamide—CALM1—superior cervical ganglion—germ cell cancer	0.00801	0.0317	CbGeAlD
Loperamide—POMC—skin epidermis—germ cell cancer	0.00713	0.0283	CbGeAlD
Loperamide—CALM2—adrenal medulla—germ cell cancer	0.0066	0.0262	CbGeAlD
Loperamide—CALM1—adrenal medulla—germ cell cancer	0.00657	0.026	CbGeAlD
Loperamide—POMC—ganglion—germ cell cancer	0.006	0.0238	CbGeAlD
Loperamide—Ileus paralytic—Vinblastine—germ cell cancer	0.00551	0.0559	CcSEcCtD
Loperamide—Megacolon—Methotrexate—germ cell cancer	0.00495	0.0503	CcSEcCtD
Loperamide—POMC—blood vessel—germ cell cancer	0.00477	0.0189	CbGeAlD
Loperamide—CALM1—trigeminal nerve—germ cell cancer	0.00452	0.0179	CbGeAlD
Loperamide—OPRM1—telencephalic ventricle—germ cell cancer	0.00363	0.0144	CbGeAlD
Loperamide—POMC—neck—germ cell cancer	0.00341	0.0135	CbGeAlD
Loperamide—Ileus—Vinblastine—germ cell cancer	0.00336	0.0342	CcSEcCtD
Loperamide—OPRD1—ganglion—germ cell cancer	0.00331	0.0131	CbGeAlD
Loperamide—CALM1—cranial nerve—germ cell cancer	0.00322	0.0128	CbGeAlD
Loperamide—CALM2—pons—germ cell cancer	0.0032	0.0127	CbGeAlD
Loperamide—CALM1—pons—germ cell cancer	0.00319	0.0126	CbGeAlD
Loperamide—CALM2—ear—germ cell cancer	0.00264	0.0105	CbGeAlD
Loperamide—CALM1—ear—germ cell cancer	0.00262	0.0104	CbGeAlD
Loperamide—POMC—brainstem—germ cell cancer	0.00261	0.0103	CbGeAlD
Loperamide—CACNA1A—brainstem—germ cell cancer	0.00249	0.00987	CbGeAlD
Loperamide—Ileus—Ifosfamide—germ cell cancer	0.00243	0.0247	CcSEcCtD
Loperamide—POMC—telencephalon—germ cell cancer	0.00232	0.00918	CbGeAlD
Loperamide—CALM2—pineal body—germ cell cancer	0.00228	0.00906	CbGeAlD
Loperamide—CALM1—pineal body—germ cell cancer	0.00227	0.00901	CbGeAlD
Loperamide—OPRM1—ganglion—germ cell cancer	0.00226	0.00895	CbGeAlD
Loperamide—CACNA1A—telencephalon—germ cell cancer	0.00221	0.00876	CbGeAlD
Loperamide—POMC—skin of body—germ cell cancer	0.00221	0.00876	CbGeAlD
Loperamide—POMC—gonad—germ cell cancer	0.00193	0.00766	CbGeAlD
Loperamide—POMC—pituitary gland—germ cell cancer	0.00189	0.00747	CbGeAlD
Loperamide—POMC—medulla oblongata—germ cell cancer	0.00182	0.00721	CbGeAlD
Loperamide—CACNA1A—medulla oblongata—germ cell cancer	0.00174	0.00688	CbGeAlD
Loperamide—POMC—adrenal gland—germ cell cancer	0.00168	0.00668	CbGeAlD
Loperamide—POMC—midbrain—germ cell cancer	0.00166	0.00659	CbGeAlD
Loperamide—Depressed level of consciousness—Ifosfamide—germ cell cancer	0.00166	0.0169	CcSEcCtD
Loperamide—CALM2—ganglion—germ cell cancer	0.00164	0.0065	CbGeAlD
Loperamide—CALM1—ganglion—germ cell cancer	0.00163	0.00647	CbGeAlD
Loperamide—POMC—spinal cord—germ cell cancer	0.00162	0.00643	CbGeAlD
Loperamide—CACNA1A—adrenal gland—germ cell cancer	0.00161	0.00637	CbGeAlD
Loperamide—POMC—female gonad—germ cell cancer	0.00157	0.00622	CbGeAlD
Loperamide—POMC—endocrine gland—germ cell cancer	0.00146	0.00579	CbGeAlD
Loperamide—POMC—head—germ cell cancer	0.00144	0.00572	CbGeAlD
Loperamide—CALM2—endothelium—germ cell cancer	0.00141	0.0056	CbGeAlD
Loperamide—CALM1—endothelium—germ cell cancer	0.00141	0.00558	CbGeAlD
Loperamide—POMC—testis—germ cell cancer	0.00139	0.00552	CbGeAlD
Loperamide—CACNA1A—head—germ cell cancer	0.00138	0.00546	CbGeAlD
Loperamide—CYP3A4—urine—germ cell cancer	0.00135	0.00535	CbGeAlD
Loperamide—CACNA1A—testis—germ cell cancer	0.00133	0.00527	CbGeAlD
Loperamide—CYP2D6—urine—germ cell cancer	0.00133	0.00527	CbGeAlD
Loperamide—CALM2—blood vessel—germ cell cancer	0.0013	0.00517	CbGeAlD
Loperamide—CALM1—blood vessel—germ cell cancer	0.0013	0.00514	CbGeAlD
Loperamide—POMC—cerebellum—germ cell cancer	0.00129	0.0051	CbGeAlD
Loperamide—OPRD1—telencephalon—germ cell cancer	0.00128	0.00506	CbGeAlD
Loperamide—CACNA1A—cerebellum—germ cell cancer	0.00123	0.00487	CbGeAlD
Loperamide—Toxic epidermal necrolysis—Dactinomycin—germ cell cancer	0.00123	0.0125	CcSEcCtD
Loperamide—Urinary retention—Ifosfamide—germ cell cancer	0.00119	0.0121	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Ifosfamide—germ cell cancer	0.00112	0.0114	CcSEcCtD
Loperamide—Anaphylactoid reaction—Cisplatin—germ cell cancer	0.00111	0.0113	CcSEcCtD
Loperamide—POMC—brain—germ cell cancer	0.00104	0.00414	CbGeAlD
Loperamide—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.00104	0.0106	CcSEcCtD
Loperamide—CALM3—trigeminal ganglion—germ cell cancer	0.00103	0.00406	CbGeAlD
Loperamide—Anaphylactoid reaction—Etoposide—germ cell cancer	0.00102	0.0103	CcSEcCtD
Loperamide—CACNA1A—brain—germ cell cancer	0.000997	0.00395	CbGeAlD
Loperamide—OPRM1—brainstem—germ cell cancer	0.000982	0.00389	CbGeAlD
Loperamide—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.000953	0.00968	CcSEcCtD
Loperamide—CALM2—neck—germ cell cancer	0.000932	0.0037	CbGeAlD
Loperamide—CALM1—neck—germ cell cancer	0.000928	0.00368	CbGeAlD
Loperamide—Erythema multiforme—Dactinomycin—germ cell cancer	0.000891	0.00905	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.000887	0.00901	CcSEcCtD
Loperamide—CALM3—eye—germ cell cancer	0.000883	0.0035	CbGeAlD
Loperamide—Discomfort—Vinblastine—germ cell cancer	0.000876	0.00889	CcSEcCtD
Loperamide—CALM3—retina—germ cell cancer	0.000875	0.00347	CbGeAlD
Loperamide—OPRM1—telencephalon—germ cell cancer	0.000871	0.00345	CbGeAlD
Loperamide—Urinary tract disorder—Ifosfamide—germ cell cancer	0.000852	0.00866	CcSEcCtD
Loperamide—Urethral disorder—Ifosfamide—germ cell cancer	0.000846	0.00859	CcSEcCtD
Loperamide—Erythema multiforme—Ifosfamide—germ cell cancer	0.000816	0.00829	CcSEcCtD
Loperamide—CALM3—telencephalon—germ cell cancer	0.000805	0.00319	CbGeAlD
Loperamide—CALM2—trigeminal ganglion—germ cell cancer	0.000805	0.00319	CbGeAlD
Loperamide—CALM1—trigeminal ganglion—germ cell cancer	0.000801	0.00318	CbGeAlD
Loperamide—OPRD1—head—germ cell cancer	0.000796	0.00315	CbGeAlD
Loperamide—Depressed level of consciousness—Methotrexate—germ cell cancer	0.000785	0.00798	CcSEcCtD
Loperamide—Immune system disorder—Ifosfamide—germ cell cancer	0.00078	0.00792	CcSEcCtD
Loperamide—CALM2—embryo—germ cell cancer	0.000778	0.00308	CbGeAlD
Loperamide—CALM1—embryo—germ cell cancer	0.000774	0.00307	CbGeAlD
Loperamide—CALM3—decidua—germ cell cancer	0.000763	0.00303	CbGeAlD
Loperamide—OPRK1—head—germ cell cancer	0.000763	0.00302	CbGeAlD
Loperamide—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000753	0.00765	CcSEcCtD
Loperamide—Discomfort—Bleomycin—germ cell cancer	0.00074	0.00751	CcSEcCtD
Loperamide—Urinary tract disorder—Cisplatin—germ cell cancer	0.000735	0.00746	CcSEcCtD
Loperamide—Urethral disorder—Cisplatin—germ cell cancer	0.000729	0.00741	CcSEcCtD
Loperamide—Constipation—Vinblastine—germ cell cancer	0.000726	0.00738	CcSEcCtD
Loperamide—Anaphylactic shock—Bleomycin—germ cell cancer	0.000718	0.00729	CcSEcCtD
Loperamide—CALM2—brainstem—germ cell cancer	0.000713	0.00282	CbGeAlD
Loperamide—CALM1—brainstem—germ cell cancer	0.000709	0.00281	CbGeAlD
Loperamide—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000695	0.00706	CcSEcCtD
Loperamide—CALM2—eye—germ cell cancer	0.000694	0.00275	CbGeAlD
Loperamide—CALM1—eye—germ cell cancer	0.00069	0.00274	CbGeAlD
Loperamide—Discomfort—Dactinomycin—germ cell cancer	0.00069	0.00701	CcSEcCtD
Loperamide—CALM2—retina—germ cell cancer	0.000687	0.00273	CbGeAlD
Loperamide—Angioedema—Ifosfamide—germ cell cancer	0.000687	0.00697	CcSEcCtD
Loperamide—CALM1—retina—germ cell cancer	0.000684	0.00271	CbGeAlD
Loperamide—OPRK1—cerebellum—germ cell cancer	0.00068	0.0027	CbGeAlD
Loperamide—Urinary tract disorder—Etoposide—germ cell cancer	0.000673	0.00684	CcSEcCtD
Loperamide—Immune system disorder—Cisplatin—germ cell cancer	0.000672	0.00683	CcSEcCtD
Loperamide—Abdominal pain—Vinblastine—germ cell cancer	0.000672	0.00682	CcSEcCtD
Loperamide—Urethral disorder—Etoposide—germ cell cancer	0.000668	0.00679	CcSEcCtD
Loperamide—CALM3—uterus—germ cell cancer	0.000668	0.00265	CbGeAlD
Loperamide—CALM3—pituitary gland—germ cell cancer	0.000656	0.0026	CbGeAlD
Loperamide—Erythema multiforme—Etoposide—germ cell cancer	0.000645	0.00655	CcSEcCtD
Loperamide—Flatulence—Cisplatin—germ cell cancer	0.000638	0.00648	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000635	0.00645	CcSEcCtD
Loperamide—CALM3—medulla oblongata—germ cell cancer	0.000633	0.00251	CbGeAlD
Loperamide—CALM2—telencephalon—germ cell cancer	0.000632	0.00251	CbGeAlD
Loperamide—Discomfort—Ifosfamide—germ cell cancer	0.000632	0.00642	CcSEcCtD
Loperamide—CALM1—telencephalon—germ cell cancer	0.000629	0.0025	CbGeAlD
Loperamide—Hypersensitivity—Vinblastine—germ cell cancer	0.000626	0.00636	CcSEcCtD
Loperamide—OPRM1—midbrain—germ cell cancer	0.000626	0.00248	CbGeAlD
Loperamide—Immune system disorder—Etoposide—germ cell cancer	0.000616	0.00626	CcSEcCtD
Loperamide—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000613	0.00623	CcSEcCtD
Loperamide—OPRM1—spinal cord—germ cell cancer	0.00061	0.00242	CbGeAlD
Loperamide—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.00061	0.0062	CcSEcCtD
Loperamide—Asthenia—Vinblastine—germ cell cancer	0.00061	0.00619	CcSEcCtD
Loperamide—CALM2—skin of body—germ cell cancer	0.000603	0.00239	CbGeAlD
Loperamide—Nervous system disorder—Ifosfamide—germ cell cancer	0.000601	0.00611	CcSEcCtD
Loperamide—CALM1—skin of body—germ cell cancer	0.000601	0.00238	CbGeAlD
Loperamide—CALM2—decidua—germ cell cancer	0.000599	0.00238	CbGeAlD
Loperamide—CALM1—decidua—germ cell cancer	0.000597	0.00237	CbGeAlD
Loperamide—Skin disorder—Ifosfamide—germ cell cancer	0.000596	0.00605	CcSEcCtD
Loperamide—CALM3—adrenal gland—germ cell cancer	0.000586	0.00232	CbGeAlD
Loperamide—Diarrhoea—Vinblastine—germ cell cancer	0.000581	0.0059	CcSEcCtD
Loperamide—CALM3—midbrain—germ cell cancer	0.000578	0.00229	CbGeAlD
Loperamide—Fatigue—Dactinomycin—germ cell cancer	0.000577	0.00586	CcSEcCtD
Loperamide—OPRD1—brain—germ cell cancer	0.000576	0.00229	CbGeAlD
Loperamide—Urticaria—Bleomycin—germ cell cancer	0.00057	0.00579	CcSEcCtD
Loperamide—CALM3—bone marrow—germ cell cancer	0.000567	0.00225	CbGeAlD
Loperamide—CALM3—spinal cord—germ cell cancer	0.000564	0.00224	CbGeAlD
Loperamide—Dizziness—Vinblastine—germ cell cancer	0.000562	0.00571	CcSEcCtD
Loperamide—OPRK1—brain—germ cell cancer	0.000553	0.00219	CbGeAlD
Loperamide—OPRM1—endocrine gland—germ cell cancer	0.00055	0.00218	CbGeAlD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000548	0.00556	CcSEcCtD
Loperamide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000547	0.00556	CcSEcCtD
Loperamide—CALM3—female gonad—germ cell cancer	0.000546	0.00216	CbGeAlD
Loperamide—Somnolence—Ifosfamide—germ cell cancer	0.000545	0.00554	CcSEcCtD
Loperamide—Discomfort—Cisplatin—germ cell cancer	0.000545	0.00553	CcSEcCtD
Loperamide—OPRM1—head—germ cell cancer	0.000543	0.00215	CbGeAlD
Loperamide—Vomiting—Vinblastine—germ cell cancer	0.00054	0.00549	CcSEcCtD
Loperamide—Headache—Vinblastine—germ cell cancer	0.000532	0.00541	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000532	0.0054	CcSEcCtD
Loperamide—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000529	0.00538	CcSEcCtD
Loperamide—Abdominal pain—Dactinomycin—germ cell cancer	0.000529	0.00537	CcSEcCtD
Loperamide—Fatigue—Ifosfamide—germ cell cancer	0.000529	0.00537	CcSEcCtD
Loperamide—Anaphylactic shock—Cisplatin—germ cell cancer	0.000529	0.00537	CcSEcCtD
Loperamide—Hypersensitivity—Bleomycin—germ cell cancer	0.000529	0.00537	CcSEcCtD
Loperamide—CALM2—gonad—germ cell cancer	0.000528	0.00209	CbGeAlD
Loperamide—CALM1—gonad—germ cell cancer	0.000525	0.00208	CbGeAlD
Loperamide—Constipation—Ifosfamide—germ cell cancer	0.000524	0.00533	CcSEcCtD
Loperamide—CALM2—uterus—germ cell cancer	0.000524	0.00208	CbGeAlD
Loperamide—OPRM1—testis—germ cell cancer	0.000524	0.00208	CbGeAlD
Loperamide—CALM1—uterus—germ cell cancer	0.000522	0.00207	CbGeAlD
Loperamide—Loss of consciousness—Etoposide—germ cell cancer	0.000522	0.0053	CcSEcCtD
Loperamide—Nervous system disorder—Cisplatin—germ cell cancer	0.000518	0.00527	CcSEcCtD
Loperamide—ABCB1—blood vessel—germ cell cancer	0.000518	0.00205	CbGeAlD
Loperamide—CALM2—pituitary gland—germ cell cancer	0.000515	0.00204	CbGeAlD
Loperamide—Asthenia—Bleomycin—germ cell cancer	0.000515	0.00523	CcSEcCtD
Loperamide—Skin disorder—Cisplatin—germ cell cancer	0.000514	0.00522	CcSEcCtD
Loperamide—CALM1—pituitary gland—germ cell cancer	0.000512	0.00203	CbGeAlD
Loperamide—Pruritus—Bleomycin—germ cell cancer	0.000508	0.00516	CcSEcCtD
Loperamide—Nausea—Vinblastine—germ cell cancer	0.000505	0.00513	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000502	0.0051	CcSEcCtD
Loperamide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000501	0.00509	CcSEcCtD
Loperamide—Discomfort—Etoposide—germ cell cancer	0.000499	0.00507	CcSEcCtD
Loperamide—CALM2—medulla oblongata—germ cell cancer	0.000497	0.00197	CbGeAlD
Loperamide—CALM1—medulla oblongata—germ cell cancer	0.000495	0.00196	CbGeAlD
Loperamide—Hypersensitivity—Dactinomycin—germ cell cancer	0.000493	0.00501	CcSEcCtD
Loperamide—Urticaria—Ifosfamide—germ cell cancer	0.000487	0.00495	CcSEcCtD
Loperamide—Abdominal pain—Ifosfamide—germ cell cancer	0.000485	0.00492	CcSEcCtD
Loperamide—CALM3—testis—germ cell cancer	0.000484	0.00192	CbGeAlD
Loperamide—Anaphylactic shock—Etoposide—germ cell cancer	0.000484	0.00492	CcSEcCtD
Loperamide—Asthenia—Dactinomycin—germ cell cancer	0.00048	0.00488	CcSEcCtD
Loperamide—Skin disorder—Etoposide—germ cell cancer	0.00047	0.00478	CcSEcCtD
Loperamide—CALM2—adrenal gland—germ cell cancer	0.00046	0.00182	CbGeAlD
Loperamide—Diarrhoea—Dactinomycin—germ cell cancer	0.000458	0.00465	CcSEcCtD
Loperamide—CALM1—adrenal gland—germ cell cancer	0.000458	0.00181	CbGeAlD
Loperamide—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000456	0.00464	CcSEcCtD
Loperamide—Vomiting—Bleomycin—germ cell cancer	0.000456	0.00463	CcSEcCtD
Loperamide—Drowsiness—Methotrexate—germ cell cancer	0.000455	0.00462	CcSEcCtD
Loperamide—CALM2—midbrain—germ cell cancer	0.000454	0.0018	CbGeAlD
Loperamide—Rash—Bleomycin—germ cell cancer	0.000452	0.0046	CcSEcCtD
Loperamide—CALM1—midbrain—germ cell cancer	0.000452	0.00179	CbGeAlD
Loperamide—Dermatitis—Bleomycin—germ cell cancer	0.000452	0.00459	CcSEcCtD
Loperamide—Hypersensitivity—Ifosfamide—germ cell cancer	0.000452	0.00459	CcSEcCtD
Loperamide—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000451	0.00458	CcSEcCtD
Loperamide—CYP2B6—skin of body—germ cell cancer	0.000449	0.00178	CbGeAlD
Loperamide—CALM3—cerebellum—germ cell cancer	0.000447	0.00177	CbGeAlD
Loperamide—CALM2—bone marrow—germ cell cancer	0.000445	0.00176	CbGeAlD
Loperamide—CALM2—spinal cord—germ cell cancer	0.000443	0.00176	CbGeAlD
Loperamide—CALM1—bone marrow—germ cell cancer	0.000443	0.00176	CbGeAlD
Loperamide—CALM1—spinal cord—germ cell cancer	0.000441	0.00175	CbGeAlD
Loperamide—Asthenia—Ifosfamide—germ cell cancer	0.00044	0.00447	CcSEcCtD
Loperamide—Pruritus—Ifosfamide—germ cell cancer	0.000434	0.00441	CcSEcCtD
Loperamide—Somnolence—Etoposide—germ cell cancer	0.000431	0.00437	CcSEcCtD
Loperamide—CALM2—female gonad—germ cell cancer	0.000429	0.0017	CbGeAlD
Loperamide—CALM1—female gonad—germ cell cancer	0.000427	0.00169	CbGeAlD
Loperamide—CYP2C8—pituitary gland—germ cell cancer	0.000427	0.00169	CbGeAlD
Loperamide—Nausea—Bleomycin—germ cell cancer	0.000426	0.00433	CcSEcCtD
Loperamide—Vomiting—Dactinomycin—germ cell cancer	0.000425	0.00432	CcSEcCtD
Loperamide—Rash—Dactinomycin—germ cell cancer	0.000422	0.00429	CcSEcCtD
Loperamide—Diarrhoea—Ifosfamide—germ cell cancer	0.00042	0.00426	CcSEcCtD
Loperamide—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000418	0.00425	CcSEcCtD
Loperamide—Fatigue—Etoposide—germ cell cancer	0.000418	0.00424	CcSEcCtD
Loperamide—Constipation—Etoposide—germ cell cancer	0.000414	0.00421	CcSEcCtD
Loperamide—Dizziness—Ifosfamide—germ cell cancer	0.000406	0.00412	CcSEcCtD
Loperamide—Urinary tract disorder—Methotrexate—germ cell cancer	0.000403	0.0041	CcSEcCtD
Loperamide—Urethral disorder—Methotrexate—germ cell cancer	0.0004	0.00407	CcSEcCtD
Loperamide—CALM2—endocrine gland—germ cell cancer	0.000399	0.00158	CbGeAlD
Loperamide—Nausea—Dactinomycin—germ cell cancer	0.000397	0.00404	CcSEcCtD
Loperamide—CALM1—endocrine gland—germ cell cancer	0.000397	0.00157	CbGeAlD
Loperamide—Gastrointestinal pain—Etoposide—germ cell cancer	0.000396	0.00402	CcSEcCtD
Loperamide—CALM2—head—germ cell cancer	0.000394	0.00156	CbGeAlD
Loperamide—CYP2D6—brainstem—germ cell cancer	0.000394	0.00156	CbGeAlD
Loperamide—OPRM1—brain—germ cell cancer	0.000393	0.00156	CbGeAlD
Loperamide—CYP2B6—gonad—germ cell cancer	0.000392	0.00156	CbGeAlD
Loperamide—CALM1—head—germ cell cancer	0.000392	0.00155	CbGeAlD
Loperamide—Vomiting—Ifosfamide—germ cell cancer	0.00039	0.00396	CcSEcCtD
Loperamide—Hypersensitivity—Cisplatin—germ cell cancer	0.000389	0.00396	CcSEcCtD
Loperamide—Rash—Ifosfamide—germ cell cancer	0.000387	0.00393	CcSEcCtD
Loperamide—Dermatitis—Ifosfamide—germ cell cancer	0.000386	0.00392	CcSEcCtD
Loperamide—Erythema multiforme—Methotrexate—germ cell cancer	0.000386	0.00392	CcSEcCtD
Loperamide—Urticaria—Etoposide—germ cell cancer	0.000385	0.00391	CcSEcCtD
Loperamide—Abdominal pain—Etoposide—germ cell cancer	0.000383	0.00389	CcSEcCtD
Loperamide—CALM2—testis—germ cell cancer	0.00038	0.00151	CbGeAlD
Loperamide—Asthenia—Cisplatin—germ cell cancer	0.000379	0.00385	CcSEcCtD
Loperamide—CALM1—testis—germ cell cancer	0.000379	0.0015	CbGeAlD
Loperamide—Immune system disorder—Methotrexate—germ cell cancer	0.000369	0.00375	CcSEcCtD
Loperamide—Nausea—Ifosfamide—germ cell cancer	0.000364	0.0037	CcSEcCtD
Loperamide—CALM3—brain—germ cell cancer	0.000363	0.00144	CbGeAlD
Loperamide—Diarrhoea—Cisplatin—germ cell cancer	0.000362	0.00367	CcSEcCtD
Loperamide—Hypersensitivity—Etoposide—germ cell cancer	0.000357	0.00362	CcSEcCtD
Loperamide—CALM2—cerebellum—germ cell cancer	0.000351	0.00139	CbGeAlD
Loperamide—CALM3—lymph node—germ cell cancer	0.000351	0.00139	CbGeAlD
Loperamide—CALM1—cerebellum—germ cell cancer	0.00035	0.00139	CbGeAlD
Loperamide—CYP2D6—telencephalon—germ cell cancer	0.000349	0.00138	CbGeAlD
Loperamide—Asthenia—Etoposide—germ cell cancer	0.000347	0.00353	CcSEcCtD
Loperamide—Pruritus—Etoposide—germ cell cancer	0.000343	0.00348	CcSEcCtD
Loperamide—CYP2B6—adrenal gland—germ cell cancer	0.000342	0.00136	CbGeAlD
Loperamide—Vomiting—Cisplatin—germ cell cancer	0.000336	0.00341	CcSEcCtD
Loperamide—Rash—Cisplatin—germ cell cancer	0.000333	0.00339	CcSEcCtD
Loperamide—Dermatitis—Cisplatin—germ cell cancer	0.000333	0.00338	CcSEcCtD
Loperamide—Diarrhoea—Etoposide—germ cell cancer	0.000331	0.00337	CcSEcCtD
Loperamide—CYP2C8—endocrine gland—germ cell cancer	0.000331	0.00131	CbGeAlD
Loperamide—Dizziness—Etoposide—germ cell cancer	0.00032	0.00325	CcSEcCtD
Loperamide—ABCB1—trigeminal ganglion—germ cell cancer	0.00032	0.00127	CbGeAlD
Loperamide—CYP2C8—testis—germ cell cancer	0.000315	0.00125	CbGeAlD
Loperamide—Nausea—Cisplatin—germ cell cancer	0.000314	0.00319	CcSEcCtD
Loperamide—ABCB1—embryo—germ cell cancer	0.000309	0.00122	CbGeAlD
Loperamide—Vomiting—Etoposide—germ cell cancer	0.000308	0.00313	CcSEcCtD
Loperamide—Rash—Etoposide—germ cell cancer	0.000305	0.0031	CcSEcCtD
Loperamide—Dermatitis—Etoposide—germ cell cancer	0.000305	0.0031	CcSEcCtD
Loperamide—Headache—Etoposide—germ cell cancer	0.000303	0.00308	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000301	0.00305	CcSEcCtD
Loperamide—Discomfort—Methotrexate—germ cell cancer	0.000299	0.00304	CcSEcCtD
Loperamide—CYP2B6—endocrine gland—germ cell cancer	0.000297	0.00118	CbGeAlD
Loperamide—CYP2B6—head—germ cell cancer	0.000293	0.00116	CbGeAlD
Loperamide—Anaphylactic shock—Methotrexate—germ cell cancer	0.00029	0.00295	CcSEcCtD
Loperamide—Nausea—Etoposide—germ cell cancer	0.000288	0.00292	CcSEcCtD
Loperamide—CALM2—brain—germ cell cancer	0.000285	0.00113	CbGeAlD
Loperamide—Nervous system disorder—Methotrexate—germ cell cancer	0.000284	0.00289	CcSEcCtD
Loperamide—CALM1—brain—germ cell cancer	0.000284	0.00113	CbGeAlD
Loperamide—CYP2B6—testis—germ cell cancer	0.000283	0.00112	CbGeAlD
Loperamide—Skin disorder—Methotrexate—germ cell cancer	0.000282	0.00286	CcSEcCtD
Loperamide—CALM2—lymph node—germ cell cancer	0.000276	0.00109	CbGeAlD
Loperamide—CALM1—lymph node—germ cell cancer	0.000274	0.00109	CbGeAlD
Loperamide—ABCB1—retina—germ cell cancer	0.000273	0.00108	CbGeAlD
Loperamide—Somnolence—Methotrexate—germ cell cancer	0.000258	0.00262	CcSEcCtD
Loperamide—Dyspepsia—Methotrexate—germ cell cancer	0.000255	0.00259	CcSEcCtD
Loperamide—ABCB1—telencephalon—germ cell cancer	0.000251	0.000996	CbGeAlD
Loperamide—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00025	0.00254	CcSEcCtD
Loperamide—Fatigue—Methotrexate—germ cell cancer	0.00025	0.00254	CcSEcCtD
Loperamide—ABCB1—decidua—germ cell cancer	0.000238	0.000944	CbGeAlD
Loperamide—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000237	0.00241	CcSEcCtD
Loperamide—CYP2D6—female gonad—germ cell cancer	0.000237	0.000939	CbGeAlD
Loperamide—CYP2C8—brain—germ cell cancer	0.000236	0.000938	CbGeAlD
Loperamide—Urticaria—Methotrexate—germ cell cancer	0.00023	0.00234	CcSEcCtD
Loperamide—Abdominal pain—Methotrexate—germ cell cancer	0.000229	0.00233	CcSEcCtD
Loperamide—CYP3A4—endocrine gland—germ cell cancer	0.000224	0.000888	CbGeAlD
Loperamide—CYP2D6—endocrine gland—germ cell cancer	0.00022	0.000873	CbGeAlD
Loperamide—CYP2D6—head—germ cell cancer	0.000218	0.000862	CbGeAlD
Loperamide—Hypersensitivity—Methotrexate—germ cell cancer	0.000214	0.00217	CcSEcCtD
Loperamide—CYP2B6—brain—germ cell cancer	0.000212	0.000841	CbGeAlD
Loperamide—CYP2D6—testis—germ cell cancer	0.00021	0.000833	CbGeAlD
Loperamide—ABCB1—gonad—germ cell cancer	0.00021	0.000831	CbGeAlD
Loperamide—ABCB1—uterus—germ cell cancer	0.000208	0.000826	CbGeAlD
Loperamide—Asthenia—Methotrexate—germ cell cancer	0.000208	0.00211	CcSEcCtD
Loperamide—Pruritus—Methotrexate—germ cell cancer	0.000205	0.00208	CcSEcCtD
Loperamide—ABCB1—pituitary gland—germ cell cancer	0.000205	0.000811	CbGeAlD
Loperamide—Diarrhoea—Methotrexate—germ cell cancer	0.000198	0.00202	CcSEcCtD
Loperamide—ABCB1—medulla oblongata—germ cell cancer	0.000197	0.000783	CbGeAlD
Loperamide—CYP2D6—cerebellum—germ cell cancer	0.000194	0.000769	CbGeAlD
Loperamide—Dizziness—Methotrexate—germ cell cancer	0.000192	0.00195	CcSEcCtD
Loperamide—Vomiting—Methotrexate—germ cell cancer	0.000184	0.00187	CcSEcCtD
Loperamide—Rash—Methotrexate—germ cell cancer	0.000183	0.00186	CcSEcCtD
Loperamide—ABCB1—adrenal gland—germ cell cancer	0.000183	0.000725	CbGeAlD
Loperamide—Dermatitis—Methotrexate—germ cell cancer	0.000183	0.00186	CcSEcCtD
Loperamide—Headache—Methotrexate—germ cell cancer	0.000182	0.00185	CcSEcCtD
Loperamide—ABCB1—midbrain—germ cell cancer	0.00018	0.000715	CbGeAlD
Loperamide—ABCB1—bone marrow—germ cell cancer	0.000177	0.000701	CbGeAlD
Loperamide—ABCB1—spinal cord—germ cell cancer	0.000176	0.000698	CbGeAlD
Loperamide—Nausea—Methotrexate—germ cell cancer	0.000172	0.00175	CcSEcCtD
Loperamide—ABCB1—female gonad—germ cell cancer	0.00017	0.000676	CbGeAlD
Loperamide—ABCB1—endocrine gland—germ cell cancer	0.000158	0.000628	CbGeAlD
Loperamide—CYP2D6—brain—germ cell cancer	0.000158	0.000625	CbGeAlD
Loperamide—ABCB1—head—germ cell cancer	0.000156	0.00062	CbGeAlD
Loperamide—ABCB1—testis—germ cell cancer	0.000151	0.000599	CbGeAlD
Loperamide—ABCB1—cerebellum—germ cell cancer	0.00014	0.000553	CbGeAlD
Loperamide—ABCB1—brain—germ cell cancer	0.000113	0.000449	CbGeAlD
Loperamide—ABCB1—lymph node—germ cell cancer	0.00011	0.000434	CbGeAlD
Loperamide—CALM3—Adaptive Immune System—FGF4—germ cell cancer	6.57e-05	0.000599	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—KIT—germ cell cancer	6.5e-05	0.000593	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—KIT—germ cell cancer	6.5e-05	0.000593	CbGpPWpGaD
Loperamide—CALM3—ErbB1 downstream signaling—HRAS—germ cell cancer	6.48e-05	0.000591	CbGpPWpGaD
Loperamide—CALM3—Disease—SLC2A3—germ cell cancer	6.4e-05	0.000584	CbGpPWpGaD
Loperamide—CALM3—VEGFA-VEGFR2 Pathway—HRAS—germ cell cancer	6.38e-05	0.000582	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—FGF4—germ cell cancer	6.35e-05	0.00058	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—FGF4—germ cell cancer	6.35e-05	0.00058	CbGpPWpGaD
Loperamide—CALM3—Immune System—PVRL2—germ cell cancer	6.31e-05	0.000575	CbGpPWpGaD
Loperamide—CALM2—ErbB1 downstream signaling—HRAS—germ cell cancer	6.27e-05	0.000572	CbGpPWpGaD
Loperamide—CALM1—ErbB1 downstream signaling—HRAS—germ cell cancer	6.27e-05	0.000572	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—AVP—germ cell cancer	6.23e-05	0.000568	CbGpPWpGaD
Loperamide—CALM2—Disease—SLC2A3—germ cell cancer	6.2e-05	0.000565	CbGpPWpGaD
Loperamide—CALM1—Disease—SLC2A3—germ cell cancer	6.2e-05	0.000565	CbGpPWpGaD
Loperamide—CALM2—VEGFA-VEGFR2 Pathway—HRAS—germ cell cancer	6.17e-05	0.000563	CbGpPWpGaD
Loperamide—CALM1—VEGFA-VEGFR2 Pathway—HRAS—germ cell cancer	6.17e-05	0.000563	CbGpPWpGaD
Loperamide—CALM1—Immune System—PVRL2—germ cell cancer	6.1e-05	0.000556	CbGpPWpGaD
Loperamide—CALM2—Immune System—PVRL2—germ cell cancer	6.1e-05	0.000556	CbGpPWpGaD
Loperamide—CALM3—Signaling by VEGF—HRAS—germ cell cancer	6.02e-05	0.000549	CbGpPWpGaD
Loperamide—CALM2—Signaling by VEGF—HRAS—germ cell cancer	5.83e-05	0.000531	CbGpPWpGaD
Loperamide—CALM1—Signaling by VEGF—HRAS—germ cell cancer	5.83e-05	0.000531	CbGpPWpGaD
Loperamide—POMC—Signaling by GPCR—HRAS—germ cell cancer	5.8e-05	0.000529	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—OXT—germ cell cancer	5.77e-05	0.000526	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—AVP—germ cell cancer	5.66e-05	0.000516	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—KITLG—germ cell cancer	5.62e-05	0.000513	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—FGF4—germ cell cancer	5.62e-05	0.000512	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—SLC2A3—germ cell cancer	5.51e-05	0.000503	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—KITLG—germ cell cancer	5.44e-05	0.000496	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—KITLG—germ cell cancer	5.44e-05	0.000496	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—SLC22A3—germ cell cancer	5.43e-05	0.000495	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—KITLG—germ cell cancer	5.4e-05	0.000492	CbGpPWpGaD
Loperamide—CALM3—Metabolism—SLC2A3—germ cell cancer	5.36e-05	0.000489	CbGpPWpGaD
Loperamide—CALM3—Metabolism—SLC22A3—germ cell cancer	5.28e-05	0.000482	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—KITLG—germ cell cancer	5.22e-05	0.000476	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—KITLG—germ cell cancer	5.22e-05	0.000476	CbGpPWpGaD
Loperamide—CALM1—Metabolism—SLC2A3—germ cell cancer	5.19e-05	0.000473	CbGpPWpGaD
Loperamide—CALM2—Metabolism—SLC2A3—germ cell cancer	5.19e-05	0.000473	CbGpPWpGaD
Loperamide—CALM3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	5.15e-05	0.000469	CbGpPWpGaD
Loperamide—CALM1—Metabolism—SLC22A3—germ cell cancer	5.11e-05	0.000466	CbGpPWpGaD
Loperamide—CALM2—Metabolism—SLC22A3—germ cell cancer	5.11e-05	0.000466	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—OXT—germ cell cancer	5.11e-05	0.000466	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—H2AFZ—germ cell cancer	5.01e-05	0.000457	CbGpPWpGaD
Loperamide—CALM1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	4.98e-05	0.000454	CbGpPWpGaD
Loperamide—CALM2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	4.98e-05	0.000454	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—OXT—germ cell cancer	4.94e-05	0.000451	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—OXT—germ cell cancer	4.94e-05	0.000451	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—FGF4—germ cell cancer	4.92e-05	0.000449	CbGpPWpGaD
Loperamide—CALM3—Downstream signaling of activated FGFR—HRAS—germ cell cancer	4.9e-05	0.000447	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—OXT—germ cell cancer	4.88e-05	0.000445	CbGpPWpGaD
Loperamide—CALM2—Downstream signaling of activated FGFR—HRAS—germ cell cancer	4.74e-05	0.000432	CbGpPWpGaD
Loperamide—CALM1—Downstream signaling of activated FGFR—HRAS—germ cell cancer	4.74e-05	0.000432	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—SLC2A3—germ cell cancer	4.67e-05	0.000426	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—KITLG—germ cell cancer	4.61e-05	0.000421	CbGpPWpGaD
Loperamide—CALM3—Downstream signal transduction—HRAS—germ cell cancer	4.6e-05	0.00042	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—SLC22A3—germ cell cancer	4.6e-05	0.000419	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR—HRAS—germ cell cancer	4.58e-05	0.000418	CbGpPWpGaD
Loperamide—CALM3—Signaling by ERBB2—HRAS—germ cell cancer	4.56e-05	0.000416	CbGpPWpGaD
Loperamide—CALM3—DAP12 signaling—HRAS—germ cell cancer	4.53e-05	0.000414	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AVP—germ cell cancer	4.51e-05	0.000411	CbGpPWpGaD
Loperamide—CALM2—Downstream signal transduction—HRAS—germ cell cancer	4.45e-05	0.000406	CbGpPWpGaD
Loperamide—CALM1—Downstream signal transduction—HRAS—germ cell cancer	4.45e-05	0.000406	CbGpPWpGaD
Loperamide—CALM3—RNF mutants show enhanced WNT signaling and proliferation—MYC—germ cell cancer	4.45e-05	0.000406	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR—HRAS—germ cell cancer	4.43e-05	0.000404	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR—HRAS—germ cell cancer	4.43e-05	0.000404	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CRABP1—germ cell cancer	4.43e-05	0.000404	CbGpPWpGaD
Loperamide—CALM2—Signaling by ERBB2—HRAS—germ cell cancer	4.41e-05	0.000402	CbGpPWpGaD
Loperamide—CALM1—Signaling by ERBB2—HRAS—germ cell cancer	4.41e-05	0.000402	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—H2AFZ—germ cell cancer	4.4e-05	0.000401	CbGpPWpGaD
Loperamide—CALM1—DAP12 signaling—HRAS—germ cell cancer	4.39e-05	0.0004	CbGpPWpGaD
Loperamide—CALM2—DAP12 signaling—HRAS—germ cell cancer	4.39e-05	0.0004	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—MYC—germ cell cancer	4.36e-05	0.000398	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CRABP1—germ cell cancer	4.31e-05	0.000393	CbGpPWpGaD
Loperamide—CALM2—RNF mutants show enhanced WNT signaling and proliferation—MYC—germ cell cancer	4.31e-05	0.000393	CbGpPWpGaD
Loperamide—CALM1—RNF mutants show enhanced WNT signaling and proliferation—MYC—germ cell cancer	4.31e-05	0.000393	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR in disease—HRAS—germ cell cancer	4.27e-05	0.000389	CbGpPWpGaD
Loperamide—CALM3—DAP12 interactions—HRAS—germ cell cancer	4.27e-05	0.000389	CbGpPWpGaD
Loperamide—CALM3—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	4.27e-05	0.000389	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR—HRAS—germ cell cancer	4.23e-05	0.000386	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR in Cancer—HRAS—germ cell cancer	4.19e-05	0.000382	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—FGFR3—germ cell cancer	4.18e-05	0.000381	CbGpPWpGaD
Loperamide—CALM3—Signaling by PDGF—HRAS—germ cell cancer	4.17e-05	0.000381	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CRABP1—germ cell cancer	4.17e-05	0.00038	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CRABP1—germ cell cancer	4.17e-05	0.00038	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—FGF4—germ cell cancer	4.16e-05	0.00038	CbGpPWpGaD
Loperamide—CALM3—Signaling by WNT in cancer—MYC—germ cell cancer	4.13e-05	0.000377	CbGpPWpGaD
Loperamide—CALM2—DAP12 interactions—HRAS—germ cell cancer	4.13e-05	0.000376	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR in disease—HRAS—germ cell cancer	4.13e-05	0.000376	CbGpPWpGaD
Loperamide—CALM1—DAP12 interactions—HRAS—germ cell cancer	4.13e-05	0.000376	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR in disease—HRAS—germ cell cancer	4.13e-05	0.000376	CbGpPWpGaD
Loperamide—CALM1—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	4.13e-05	0.000376	CbGpPWpGaD
Loperamide—CALM2—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	4.13e-05	0.000376	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR—HRAS—germ cell cancer	4.09e-05	0.000373	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR—HRAS—germ cell cancer	4.09e-05	0.000373	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—SLC2A3—germ cell cancer	4.06e-05	0.000371	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR in Cancer—HRAS—germ cell cancer	4.05e-05	0.00037	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR in Cancer—HRAS—germ cell cancer	4.05e-05	0.00037	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—KITLG—germ cell cancer	4.05e-05	0.000369	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—FGFR3—germ cell cancer	4.04e-05	0.000369	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—FGFR3—germ cell cancer	4.04e-05	0.000369	CbGpPWpGaD
Loperamide—CALM2—Signaling by PDGF—HRAS—germ cell cancer	4.03e-05	0.000368	CbGpPWpGaD
Loperamide—CALM1—Signaling by PDGF—HRAS—germ cell cancer	4.03e-05	0.000368	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—FGFR3—germ cell cancer	4.01e-05	0.000366	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—SLC22A3—germ cell cancer	4e-05	0.000365	CbGpPWpGaD
Loperamide—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	4e-05	0.000365	CbGpPWpGaD
Loperamide—CALM2—Signaling by WNT in cancer—MYC—germ cell cancer	4e-05	0.000365	CbGpPWpGaD
Loperamide—CALM1—Signaling by WNT in cancer—MYC—germ cell cancer	4e-05	0.000365	CbGpPWpGaD
Loperamide—CALM3—Immune System—FGF4—germ cell cancer	3.98e-05	0.000363	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AVP—germ cell cancer	3.95e-05	0.000361	CbGpPWpGaD
Loperamide—CALM3—B Cell Activation—HRAS—germ cell cancer	3.95e-05	0.00036	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—FGFR3—germ cell cancer	3.88e-05	0.000354	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—FGFR3—germ cell cancer	3.88e-05	0.000354	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	3.87e-05	0.000353	CbGpPWpGaD
Loperamide—CALM3—Transmission across Chemical Synapses—HRAS—germ cell cancer	3.87e-05	0.000353	CbGpPWpGaD
Loperamide—CALM2—Immune System—FGF4—germ cell cancer	3.85e-05	0.000352	CbGpPWpGaD
Loperamide—CALM1—Immune System—FGF4—germ cell cancer	3.85e-05	0.000352	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—KIT—germ cell cancer	3.83e-05	0.00035	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—SLC2A3—germ cell cancer	3.83e-05	0.000349	CbGpPWpGaD
Loperamide—CALM2—B Cell Activation—HRAS—germ cell cancer	3.82e-05	0.000348	CbGpPWpGaD
Loperamide—CALM1—B Cell Activation—HRAS—germ cell cancer	3.82e-05	0.000348	CbGpPWpGaD
Loperamide—CALM3—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	3.78e-05	0.000345	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—SLC22A3—germ cell cancer	3.77e-05	0.000344	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CRABP1—germ cell cancer	3.75e-05	0.000342	CbGpPWpGaD
Loperamide—CALM2—Transmission across Chemical Synapses—HRAS—germ cell cancer	3.74e-05	0.000341	CbGpPWpGaD
Loperamide—CALM1—Transmission across Chemical Synapses—HRAS—germ cell cancer	3.74e-05	0.000341	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—H2AFZ—germ cell cancer	3.72e-05	0.000339	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—KIT—germ cell cancer	3.71e-05	0.000338	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—KIT—germ cell cancer	3.71e-05	0.000338	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—KIT—germ cell cancer	3.68e-05	0.000336	CbGpPWpGaD
Loperamide—CALM3—Disease—FGF4—germ cell cancer	3.68e-05	0.000336	CbGpPWpGaD
Loperamide—CALM2—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	3.65e-05	0.000333	CbGpPWpGaD
Loperamide—CALM1—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	3.65e-05	0.000333	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—TP53—germ cell cancer	3.58e-05	0.000327	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—KIT—germ cell cancer	3.56e-05	0.000325	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—KIT—germ cell cancer	3.56e-05	0.000325	CbGpPWpGaD
Loperamide—CALM2—Disease—FGF4—germ cell cancer	3.56e-05	0.000325	CbGpPWpGaD
Loperamide—CALM1—Disease—FGF4—germ cell cancer	3.56e-05	0.000325	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AVP—germ cell cancer	3.5e-05	0.000319	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—FGFR3—germ cell cancer	3.43e-05	0.000313	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—HRAS—germ cell cancer	3.43e-05	0.000313	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—KITLG—germ cell cancer	3.42e-05	0.000312	CbGpPWpGaD
Loperamide—CALM3—Signaling by Wnt—MYC—germ cell cancer	3.41e-05	0.000311	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AVP—germ cell cancer	3.39e-05	0.000309	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AVP—germ cell cancer	3.39e-05	0.000309	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AVP—germ cell cancer	3.34e-05	0.000305	CbGpPWpGaD
Loperamide—CALM2—Signaling by Wnt—MYC—germ cell cancer	3.3e-05	0.000301	CbGpPWpGaD
Loperamide—CALM1—Signaling by Wnt—MYC—germ cell cancer	3.3e-05	0.000301	CbGpPWpGaD
Loperamide—CALM3—Disease—H2AFZ—germ cell cancer	3.28e-05	0.0003	CbGpPWpGaD
Loperamide—CALM3—Immune System—KITLG—germ cell cancer	3.27e-05	0.000299	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CRABP1—germ cell cancer	3.26e-05	0.000298	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	3.18e-05	0.00029	CbGpPWpGaD
Loperamide—CALM1—Disease—H2AFZ—germ cell cancer	3.18e-05	0.00029	CbGpPWpGaD
Loperamide—CALM2—Disease—H2AFZ—germ cell cancer	3.18e-05	0.00029	CbGpPWpGaD
Loperamide—CALM2—Immune System—KITLG—germ cell cancer	3.17e-05	0.000289	CbGpPWpGaD
Loperamide—CALM1—Immune System—KITLG—germ cell cancer	3.17e-05	0.000289	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—KIT—germ cell cancer	3.15e-05	0.000287	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CRABP1—germ cell cancer	3.08e-05	0.000281	CbGpPWpGaD
Loperamide—CALM3—Disease—KITLG—germ cell cancer	3.02e-05	0.000276	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—OXT—germ cell cancer	3.02e-05	0.000275	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—FGFR3—germ cell cancer	3.01e-05	0.000274	CbGpPWpGaD
Loperamide—CALM3—Neuronal System—HRAS—germ cell cancer	2.96e-05	0.00027	CbGpPWpGaD
Loperamide—CALM1—Disease—KITLG—germ cell cancer	2.92e-05	0.000267	CbGpPWpGaD
Loperamide—CALM2—Disease—KITLG—germ cell cancer	2.92e-05	0.000267	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—OXT—germ cell cancer	2.92e-05	0.000266	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—OXT—germ cell cancer	2.92e-05	0.000266	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—HRAS—germ cell cancer	2.91e-05	0.000265	CbGpPWpGaD
Loperamide—CALM2—Neuronal System—HRAS—germ cell cancer	2.87e-05	0.000262	CbGpPWpGaD
Loperamide—CALM1—Neuronal System—HRAS—germ cell cancer	2.87e-05	0.000262	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—HRAS—germ cell cancer	2.81e-05	0.000256	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—HRAS—germ cell cancer	2.81e-05	0.000256	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—KIT—germ cell cancer	2.76e-05	0.000252	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—FGF4—germ cell cancer	2.58e-05	0.000235	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—FGFR3—germ cell cancer	2.54e-05	0.000232	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—SLC2A3—germ cell cancer	2.5e-05	0.000228	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—FGF4—germ cell cancer	2.49e-05	0.000227	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—FGF4—germ cell cancer	2.49e-05	0.000227	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—SLC22A3—germ cell cancer	2.47e-05	0.000225	CbGpPWpGaD
Loperamide—CALM3—Immune System—FGFR3—germ cell cancer	2.43e-05	0.000222	CbGpPWpGaD
Loperamide—CALM1—Immune System—FGFR3—germ cell cancer	2.35e-05	0.000215	CbGpPWpGaD
Loperamide—CALM2—Immune System—FGFR3—germ cell cancer	2.35e-05	0.000215	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—KIT—germ cell cancer	2.33e-05	0.000213	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—HRAS—germ cell cancer	2.3e-05	0.00021	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—H2AFZ—germ cell cancer	2.3e-05	0.00021	CbGpPWpGaD
Loperamide—CALM3—Disease—FGFR3—germ cell cancer	2.25e-05	0.000205	CbGpPWpGaD
Loperamide—CALM3—Immune System—KIT—germ cell cancer	2.23e-05	0.000204	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—H2AFZ—germ cell cancer	2.23e-05	0.000203	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—H2AFZ—germ cell cancer	2.23e-05	0.000203	CbGpPWpGaD
Loperamide—CALM2—Disease—FGFR3—germ cell cancer	2.17e-05	0.000198	CbGpPWpGaD
Loperamide—CALM1—Disease—FGFR3—germ cell cancer	2.17e-05	0.000198	CbGpPWpGaD
Loperamide—CALM1—Immune System—KIT—germ cell cancer	2.16e-05	0.000197	CbGpPWpGaD
Loperamide—CALM2—Immune System—KIT—germ cell cancer	2.16e-05	0.000197	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—KITLG—germ cell cancer	2.12e-05	0.000193	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AVP—germ cell cancer	2.07e-05	0.000189	CbGpPWpGaD
Loperamide—CALM3—Disease—KIT—germ cell cancer	2.06e-05	0.000188	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—KITLG—germ cell cancer	2.05e-05	0.000187	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—KITLG—germ cell cancer	2.05e-05	0.000187	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—HRAS—germ cell cancer	2.02e-05	0.000184	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CRABP1—germ cell cancer	2.01e-05	0.000183	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AVP—germ cell cancer	2e-05	0.000183	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AVP—germ cell cancer	2e-05	0.000183	CbGpPWpGaD
Loperamide—CALM2—Disease—KIT—germ cell cancer	1.99e-05	0.000182	CbGpPWpGaD
Loperamide—CALM1—Disease—KIT—germ cell cancer	1.99e-05	0.000182	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TP53—germ cell cancer	1.92e-05	0.000176	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TP53—germ cell cancer	1.86e-05	0.00017	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TP53—germ cell cancer	1.86e-05	0.00017	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—HRAS—germ cell cancer	1.84e-05	0.000168	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—HRAS—germ cell cancer	1.78e-05	0.000162	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—HRAS—germ cell cancer	1.78e-05	0.000162	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MYC—germ cell cancer	1.73e-05	0.000158	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—HRAS—germ cell cancer	1.71e-05	0.000156	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—HRAS—germ cell cancer	1.66e-05	0.000151	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—HRAS—germ cell cancer	1.6e-05	0.000146	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—HRAS—germ cell cancer	1.6e-05	0.000146	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—HRAS—germ cell cancer	1.59e-05	0.000145	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—FGFR3—germ cell cancer	1.57e-05	0.000143	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—HRAS—germ cell cancer	1.54e-05	0.00014	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—HRAS—germ cell cancer	1.54e-05	0.00014	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—FGFR3—germ cell cancer	1.52e-05	0.000139	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—FGFR3—germ cell cancer	1.52e-05	0.000139	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MYC—germ cell cancer	1.52e-05	0.000139	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—KIT—germ cell cancer	1.44e-05	0.000132	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TP53—germ cell cancer	1.42e-05	0.00013	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—KIT—germ cell cancer	1.4e-05	0.000127	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—KIT—germ cell cancer	1.4e-05	0.000127	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—HRAS—germ cell cancer	1.36e-05	0.000124	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MYC—germ cell cancer	1.28e-05	0.000117	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TP53—germ cell cancer	1.25e-05	0.000114	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HRAS—germ cell cancer	1.19e-05	0.000109	CbGpPWpGaD
Loperamide—CALM3—Disease—MYC—germ cell cancer	1.13e-05	0.000104	CbGpPWpGaD
Loperamide—CALM1—Disease—MYC—germ cell cancer	1.1e-05	0.0001	CbGpPWpGaD
Loperamide—CALM2—Disease—MYC—germ cell cancer	1.1e-05	0.0001	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—HRAS—germ cell cancer	1.06e-05	9.64e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TP53—germ cell cancer	1.05e-05	9.62e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—HRAS—germ cell cancer	1.02e-05	9.32e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—HRAS—germ cell cancer	1.02e-05	9.32e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HRAS—germ cell cancer	1.01e-05	9.2e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—HRAS—germ cell cancer	9.65e-06	8.81e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—HRAS—germ cell cancer	9.34e-06	8.52e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—HRAS—germ cell cancer	9.34e-06	8.52e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—HRAS—germ cell cancer	8.91e-06	8.13e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—HRAS—germ cell cancer	8.62e-06	7.86e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—HRAS—germ cell cancer	8.62e-06	7.86e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MYC—germ cell cancer	7.95e-06	7.25e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MYC—germ cell cancer	7.69e-06	7.01e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MYC—germ cell cancer	7.69e-06	7.01e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TP53—germ cell cancer	6.53e-06	5.95e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TP53—germ cell cancer	6.31e-06	5.76e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TP53—germ cell cancer	6.31e-06	5.76e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HRAS—germ cell cancer	6.24e-06	5.69e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HRAS—germ cell cancer	6.04e-06	5.51e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HRAS—germ cell cancer	6.04e-06	5.51e-05	CbGpPWpGaD
